Literature DB >> 2348298

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

B A Claesson1, R Schneerson, B Trollfors, T Lagergård, J Taranger, J B Robbins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348298     DOI: 10.1016/s0022-3476(05)80655-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Immunogenicity and tolerance of H. influenzae type b, tetanus toxoid conjugate vaccine given concurrently or in combination.

Authors:  A Kumar; A K Dutta; A Saili; S Nangia; R Dutta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

2.  Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Authors:  J Kuo; M Douglas; H K Ree; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 3.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

4.  Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children.

Authors:  Do Gia Canh; Feng-ying Kimi Lin; Vu Dinh Thiem; Dang Duc Trach; Nguyen Dinh Trong; Nguyen Duc Mao; Steven Hunt; Rachel Schneerson; John B Robbins; Chiayung Chu; Joseph Shiloach; Dolores A Bryla; Marie-Claude Bonnet; Dominique Schulz; Shousun C Szu
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.609

5.  Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.

Authors:  Magnus Gottfredsson; Ingi K Reynisson; Ragnar F Ingvarsson; Hafrun Kristjansdottir; Martina V Nardini; Jon F Sigurdsson; Rachel Schneerson; John B Robbins; Mark A Miller
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.